Anti-CD28 Antibody

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
ONL-1204ONL-1204Phase 2 ClinicalOnl TherapeuticsGlaucoma, Open-Angle; Retinal Detachment; Geographic Atrophy
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
KanglaiteApprovedZhejiang Kanglaite Pharmaceutical Co LtdKanglaiteMainland ChinaLiver Neoplasms; Carcinoma, Non-Small-Cell LungZhejiang Kanglaite Pharmaceutical Co Ltd1997-01-01Liver Neoplasms; Solid tumours; Neoplasms; Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호